The effects of shATG7 and ATG7-IN-1 treatment in immunocompromised mice (BALB/c-Nude mice) were examined to assess the effect of adaptive immunity on ATG7-mediated tumor growth and tumor weight reduction. Here, ATG7 is linked to neoplasm.